Log in
Enquire now
‌

US Patent 8138169 Combination therapy for bipolar disorder

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
81381690
Patent Inventor Names
Bryan T. Oronsky0
Neil C. Oronsky0
Date of Patent
March 20, 2012
0
Patent Application Number
124221560
Date Filed
April 10, 2009
0
Patent Citations Received
‌
US Patent 11977085 Date rape drug detection device and method of using same
0
‌
US Patent 11707466 Immediate release multilayer tablet
0
‌
US Patent 11767293 Crystal forms and production methods thereof
‌
US Patent 11951111 Immediate release multilayer tablet
0
Patent Primary Examiner
‌
Jennifer M Kim
0
Patent abstract

Treatment regimens for mood disorders that include administration of buprenorphine, alone or in combination with additional pharmacological agents are described. Specifically, treatment regimens that alleviate racing thoughts associated with bipolar disorder, and pharmaceutical compositions and kits for use therein are described. Dosing regimens, compositions, and kits including buprenorphine for treating mania associated with opioid withdrawal are also described.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8138169 Combination therapy for bipolar disorder

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.